John Darrell Van Horn1, Arthur W Toga. 1. Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-7334, USA. jvanhorn@loni.ucla.edu
Abstract
PURPOSE OF REVIEW: The intent of this study is to review trends in multicenter neuroimaging trials and their value for research and implications for clinical treatment. RECENT FINDINGS: The rise in availability of MRI for detecting disorders in the living brain has made it an attractive technology for assessing neural structure and function in a number of prominent diseases. Geographic factors underlying diseased populations coupled with complementary neuroimaging research programs have led to an increase in multicenter neuroimaging trials and consortia. Neuroimaging has become a major focus for multiinstitutional research in progressive changes in brain architecture, proxy biomarkers of treatment response, and the effects of disease on patterns of cognitive activation and connectivity. Notable consortia and research trial studies have focused on Alzheimer's disease, pediatric brain cancer, and fetal alcohol syndrome, in addition to multiinstitutional collaborative programs for mapping the normal brain. Such large-scale efforts necessitate close coordination of image data collection protocols, ontology development, computational requirements, concerted data archiving, and sharing. SUMMARY: Multicenter neuroimaging trials, consortia, and collaboratives enable the acquisition of large-scale, purpose-driven datasets that can then be used by the broader community to model and predict clinical outcomes as well as guide clinicians in selecting treatment options for neurological disease.
PURPOSE OF REVIEW: The intent of this study is to review trends in multicenter neuroimaging trials and their value for research and implications for clinical treatment. RECENT FINDINGS: The rise in availability of MRI for detecting disorders in the living brain has made it an attractive technology for assessing neural structure and function in a number of prominent diseases. Geographic factors underlying diseased populations coupled with complementary neuroimaging research programs have led to an increase in multicenter neuroimaging trials and consortia. Neuroimaging has become a major focus for multiinstitutional research in progressive changes in brain architecture, proxy biomarkers of treatment response, and the effects of disease on patterns of cognitive activation and connectivity. Notable consortia and research trial studies have focused on Alzheimer's disease, pediatric brain cancer, and fetal alcohol syndrome, in addition to multiinstitutional collaborative programs for mapping the normal brain. Such large-scale efforts necessitate close coordination of image data collection protocols, ontology development, computational requirements, concerted data archiving, and sharing. SUMMARY: Multicenter neuroimaging trials, consortia, and collaboratives enable the acquisition of large-scale, purpose-driven datasets that can then be used by the broader community to model and predict clinical outcomes as well as guide clinicians in selecting treatment options for neurological disease.
Authors: Gary W Small; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Susan Y Bookheimer; Karen J Miller; Helen Lavretsky; Alison C Burggren; Greg M Cole; Harry V Vinters; Paul M Thompson; S-C Huang; N Satyamurthy; Michael E Phelps; Jorge R Barrio Journal: N Engl J Med Date: 2006-12-21 Impact factor: 91.245
Authors: Lee Friedman; Hal Stern; Gregory G Brown; Daniel H Mathalon; Jessica Turner; Gary H Glover; Randy L Gollub; John Lauriello; Kelvin O Lim; Tyrone Cannon; Douglas N Greve; Henry Jeremy Bockholt; Aysenil Belger; Bryon Mueller; Michael J Doty; Jianchun He; William Wells; Padhraic Smyth; Steve Pieper; Seyoung Kim; Marek Kubicki; Mark Vangel; Steven G Potkin Journal: Hum Brain Mapp Date: 2008-08 Impact factor: 5.038
Authors: H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen Journal: JAMA Date: 2008-08-06 Impact factor: 56.272
Authors: Harald Hampel; Katharina Bürger; Stefan J Teipel; Arun L W Bokde; Henrik Zetterberg; Kaj Blennow Journal: Alzheimers Dement Date: 2007-12-21 Impact factor: 21.566
Authors: T Young Poussaint; P C Phillips; S Vajapeyam; F H Fahey; R L Robertson; S Osganian; U Ramamurthy; R V Mulkern; S T Treves; J M Boyett; L E Kun Journal: AJNR Am J Neuroradiol Date: 2007-04 Impact factor: 3.825
Authors: Christine Fennema-Notestine; Anthony C Gamst; Brian T Quinn; Jenni Pacheco; Terry L Jernigan; Leon Thal; Randy Buckner; Ron Killiany; Deborah Blacker; Anders M Dale; Bruce Fischl; Brad Dickerson; Randy L Gollub Journal: Neuroinformatics Date: 2007-11-13
Authors: Gary H Glover; Bryon A Mueller; Jessica A Turner; Theo G M van Erp; Thomas T Liu; Douglas N Greve; James T Voyvodic; Jerod Rasmussen; Gregory G Brown; David B Keator; Vince D Calhoun; Hyo Jong Lee; Judith M Ford; Daniel H Mathalon; Michele Diaz; Daniel S O'Leary; Syam Gadde; Adrian Preda; Kelvin O Lim; Cynthia G Wible; Hal S Stern; Aysenil Belger; Gregory McCarthy; Burak Ozyurt; Steven G Potkin Journal: J Magn Reson Imaging Date: 2012-02-07 Impact factor: 4.813
Authors: S Deprez; Michiel B de Ruiter; S Bogaert; R Peeters; J Belderbos; D De Ruysscher; S Schagen; S Sunaert; P Pullens; E Achten Journal: Neuroradiology Date: 2018-04-14 Impact factor: 2.804
Authors: Arthur W Toga; Ian Foster; Carl Kesselman; Ravi Madduri; Kyle Chard; Eric W Deutsch; Nathan D Price; Gustavo Glusman; Benjamin D Heavner; Ivo D Dinov; Joseph Ames; John Van Horn; Roger Kramer; Leroy Hood Journal: J Am Med Inform Assoc Date: 2015-07-21 Impact factor: 4.497
Authors: Dylan G Gee; Sarah C McEwen; Jennifer K Forsyth; Kristen M Haut; Carrie E Bearden; Jean Addington; Bradley Goodyear; Kristin S Cadenhead; Heline Mirzakhanian; Barbara A Cornblatt; Doreen Olvet; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Aysenil Belger; Larry J Seidman; Heidi Thermenos; Ming T Tsuang; Theo G M van Erp; Elaine F Walker; Stephan Hamann; Scott W Woods; Todd Constable; Tyrone D Cannon Journal: Hum Brain Mapp Date: 2015-03-28 Impact factor: 5.038
Authors: David R Roalf; Kosha Ruparel; Raquel E Gur; Warren Bilker; Raphael Gerraty; Mark A Elliott; R Sean Gallagher; Laura Almasy; Michael F Pogue-Geile; Konasale Prasad; Joel Wood; Vishwajit L Nimgaonkar; Ruben C Gur Journal: Neuropsychology Date: 2013-12-23 Impact factor: 3.295